Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (14,551,000) $ (13,755,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 948,000 452,000
Write down of inventory 324,000  
Adjustment to property and equipment for sales type leases (321,000)  
Loss from impairment of property and equipment 96,000 0
Stock-based compensation 5,190,000 1,082,000
Noncash interest expense 5,000 2,344,000
Noncash lease expense 197,000  
Recovery of allowance for doubtful accounts   (63,000)
Change in fair value of derivative liability   1,425,000
Change in fair value of common stock warrant liability   736,000
Change in fair value of earn-out liability (4,226,000)  
Change in fair value of contingently issuable common stock (1,472,000)  
Change in fair value of public warrant liability (5,586,000) 0
Changes in operating assets and liabilities    
Accounts receivable (2,112,000) (874,000)
Inventory (6,985,000) (433,000)
Commission assets (351,000) (391,000)
Contract assets 108,000 (119,000)
Prepaid expenses and other current assets (5,280,000) (4,104,000)
Accounts payable (1,867,000) 1,194,000
Deferred revenue 2,778,000 (621,000)
Deferred rent (468,000) (11,000)
Accrued expenses and other current liabilities (2,065,000) 1,100,000
Operating lease liabilities (229,000)  
Net cash used in operating activities (35,867,000) (12,038,000)
Cash flows from investing activities:    
Development of internal-use software (646,000)  
Purchases of property and equipment (323,000) (2,522,000)
Net cash used in investing activities (969,000) (2,522,000)
Cash flows from financing activities:    
Proceeds from exercise of stock options 216,000 455,000
Repayment of financing obligations   (359,000)
Proceeds from long-term debt, net of issuance costs   31,882,000
Net cash provided by financing activities 216,000 31,978,000
Net increase (decrease) in cash, cash equivalents and restricted cash (36,620,000) 17,418,000
Cash, cash equivalents and restricted cash    
Cash, cash equivalents and restricted cash at beginning of period 308,167,000 4,704,000
Cash, cash equivalents and restricted cash at end of period 271,547,000 22,122,000
Supplemental disclosure of cash flow information    
Cash paid for interest 133,000 103,000
Supplemental disclosure of non-cash activities    
Transfer of inventory to property and equipment 4,620,000  
Capital expenditures incurred but not yet paid $ 1,693,000  
Issuance of equity classified warrants   $ 1,000